Notes
J . Org. Chem., Vol. 61, No. 21, 1996 7625
quantitatively crude 2′-OAc dimer 11. This product was submit-
ted directly to desilylation. 1H NMR (300 MHz, CDCl3) δ: 1.08
(s, 9H); 1.09 (s, 9H); 1. 79 (m, 2H); 1.87 (d, 3H, J ) 1.2 Hz);
2.12 (s, 3H); 2.21 (m, 2H); 2.74-2.94 (m, 3H); 3.18-3.32 (m, 2H);
3.82-3.93 (m, 1H); 4.00-4.10 (m, 3H), 4.12-4.18 (m, 1H); 5.43
(d, 1H, J ) 8.2 Hz); 5.54 (m, 1H); 5.75 (t, 1H, J ) 0.6 Hz); 6.08
(t, 1H, J ) 7 Hz); 6.90 (d, 1H, J ) 1.1 Hz); 7.33-7.49 (m, 12H);
7.51 (d, 1H, J ) 8.2 Hz); 7.61-7.67 (m, 8H); 8.92 (s, 1H); 9.04
(s, 1H). 13C NMR (75 MHz, CDCl3) δ: 12.4, 19.1, 19.3, 20.7,
25.2, 26.88, 26.9, 35.4, 38.5, 49.0, 50.2, 63.4, 75.9, 76.5, 83.7,
84.6, 87.7, 91.0, 103.0, 111.4, 128.0, 128.1, 130.1, 130.2, 130.3,
130.35, 132.2, 132.7, 132.8, 132.9, 135.4, 135.7, 135.9, 136.8,
140.5, 150.0, 150.2, 163.6, 163.7, 169.4. FABMS m/z: 1085 (M
+ Na+, 20%); 1063 (M+, 6); 1005 (12); 937 (13); 623 (18); 603
(46); 569 (23); 511 (21); 491 (21); 461 (11); 401 (17): UV
(CH2Cl2): λmax 261 (ꢀ 17 400).
5.62 (m, 1H); 5.76, 5.80 (dd, 1H); 6.03 (dt, 1H); 6.82 (d, 4H); 7.04
(m, 1H); 7.22 (m, 1H); 7.30 (m, 6H); 7.41 (dd, 2H); 7.66 (dd, 1H).
31P-NMR (121 MHz, CDCl3) δ: 148.8 (s); 149.5 (s). FABMS
m/z: 1661 (0.49); 1190 ((M + (iPr)2N)+, 0.13); 1013 (M + Na+,
0.25); 1090 (M + H+, 0.3); 303 (100).
5′-Br om o-5′-d eoxyth ym id in e (26). (Procedure modified af-
ter ref 18). A mixture of thymidine (441.5 mg, 1.823 mmol) and
triphenylphosphine (956 mg, 3.65 mmol) was coevaporated from
pyridine (20 mL) and dried, in vacuo, at 55 °C for 2 h. The solid
was subsequently dissolved in pyridine (35 mL), and a solution
of tetrabromomethane (1.088 g; 3.28 mmol) in pyridine (5 mL)
was added. The yellow solution was stirred for 1 h (TLC: ethyl
acetate/CH2Cl2/methanol, 60:40:10, Rf thymidine 0.28, Rf product
0.53). The mixture was then evaporated to dryness, in vacuo.
The resulting yellow-brown oil was chromatographed on silica
gel (50 g), with CH2Cl2/ethyl acetate (2:3) and a stepwise MeOH
gradient (4-6%). The first product fractions contained some
triphenyl phosphinoxide that was removed by washing the solid
obtained after evaporation with CH2Cl2 (3 × 5 mL). The
combined product fractions gave 26 (368 mg; 1.21 mmol) as a
colorless foam. Yield: 66%. Mp: 157-158 °C (lit.16 mp 157-
158 °C). 1H-NMR (200 MHz, DMSO-d6) δ: 1.79 (s, 3H); 2.09,
2.28 (2 × m, 2H); 3.65 (dd, 1H, J ) 6.3, 10.2 Hz); 3.75 (dd, 1H,
J ) 5.7, 10.7 Hz); 3.93 (m, 1H); 4.23 (m, 1H,); 5.49 (br d, 1H);
6.23 (t, 1H, J ) 6.4 Hz), 7.51 (s, 1H); 11.33 (br s, 1H). 13C-NMR
(50 MHz, DMSO-d6) δ: 11.78, 33.38, 37.59, 71.57, 83.49, 84.73,
109.47, 135.62, 150.06, 163.25. UV (MeOH): λmax (nm) 266 (ꢀ
18 000); 226 (ꢀ 5 000).
5′-Br om o-5′-d e oxy-3′-(t er t -b u t yld ip h e n ylsilyl)t h ym i-
d in e (27). Bromide 26 (528.3 mg, 1.73 mmol) was dissolved in
warm MeOH and coevaporated from toluene. Imidazole (353.6
mg, 5.19 mmol) was added, and the mixture was dried, in vacuo,
at 50 °C for 1 h. Subsequently, the solid was dissolved in
tetrahydrofuran (10.5 mL), and tert-butyldiphenylsilyl chloride
(665 µL, 2.60 mmol) was slowly added, causing precipitation of
imidazolium chloride. The suspension was heated to 40 °C for
14 h (TLC: CH2Cl2/ethyl acetate/methanol, 75:25:5, Rf 26 0.22,
Rf product 0.79). MeOH (4 mL) was added, and the solution
was stirred for 10 min and then evaporated to dryness, in vacuo.
The resulting solid was taken up in CH2Cl2 (20 mL) and water
(1 mL), and the organic phase was extracted with ice-cold 0.1
M hydrochloric acid (2 × 10 mL) and saturated aqueous sodium
bicarbonate (10 mL). The aqueous phases were back-extracted
with CH2Cl2, and the combined organic phases were evaporated
to dryness. The resulting foam was purified by column chro-
matography on silica (95 g) with CH2Cl2 and a stepwise MeOH
gradient (1.5-7%). Silyl ether 27 was isolated as a white foam
(882 mg, 1.62 mmol, 94% yield). 1H-NMR (200 MHz, CDCl3) δ:
1.10 (s, 9H); 1.89 (s, 3H); 1.99 (m, 1H); 2.37 (ddd, 1H, J ) 2.4,
5.9, 13.1 Hz); 2.84 (dd, 1H, J ) 3.4, 11.3 Hz); 3.34 (dd, 1H, J )
3.5, 11.3 Hz); 4.09 (m, 1H); 4.36 (m, 1H); 6.41 (dd, 1H, J ) 5.8,
8.2 Hz); 7.33 (s, 1H); 7.43 (m, 6H); 7.66 (m, 4H); 8.84 (br s, 1H).
13C-NMR (75 MHz, CDCl3) δ: 12.80, 19.19, 27.10, 33.60, 40.86,
74.86, 84.72, 85.25, 111.67, 128.37, 128.41, 130.58, 130.68,
133.14, 133.38, 135.80, 136.14, 150.76, 164.19; FAB-MS m/z:
545, 543 (M + H+). UV (CH2Cl2) λmax 265 (ꢀ 10 700); 228 (ꢀ
7 100).
Com p ou n d 29. Cesium carbonate (29.4 mg, 0.0901 mmol,
flame dried, in vacuo, for 2 min), bromide 27 (11.3 mg, 0.0207
mmol), and thioester 8 (10.0 mg, 0.0180 mmol) were mixed and
dried, in vacuo, at 40 °C for 1 h. Subsequently, tetrahydrofuran
(0.7 mL) was added, and the suspension was stirred at rt. The
reaction was followed by TLC (methanol/hexane/CH2Cl2, 5:20:
75, Rf bromide 0.51, Rf thioester 0.22, Rf 2′-OAc-product 0.18).
After 10 h acetate buffer (45 µL; 3 M acetic acid, 1 M sodium
acetate) was added, and the reaction mixture was evaporated
to dryness, in vacuo. The resulting solid was taken up in half-
saturated brine (3 mL) and CH2Cl2 (3 mL). The aqueous phase
was extracted with CH2Cl2 (4 × 3 mL). The combined organic
phases were washed with brine (10 mL) and evaporated to
dryness, in vacuo. The residue was purified by column chro-
matography on silica (3 g) with methanol/ethanol/water/CH2Cl2
(1:1:0.2:98, stepwise gradient to 3:3:0.2: 94). Compound 29 (9.6
mg, 0.0094 mmol; 52%) was isolated as a white foam. Fractions
containing compound 28, which eluted after 29, were combined,
dried in vacuo, and acetylated. To this end, a 0.07 M solution
of 28 in pyridine was treated with 2 equiv of acetic anhydride.
The solution was stirred overnight, quenched with MeOH, and
Com p ou n d 12. 2′-OAc dimer 11 (181 mg, 170 µmol) was
dissolved in dry pyridine (0.5 mL) in a 10 mL polypropylene tube
under Ar. An HF/pyridine solution (0.7 mL, 3.29 mmol, 4.7 M
in pyridine) was added, and the resulting solution was stirred
for 3 h at rt before methoxytrimethylsilane (4 mL, 28 mmol) was
added. A white precipitate formed. Stirring continued for 30
min before the mixture was concentrated in vacuo. The residue
was chromatographed on silica (22 g) with CH2Cl2/EtOH/MeOH/
water (86:7:7:0.25 and 83:9:8:0.25) to yield diol 12 as a white
glass (79.5 mg, 135 µmol). Yield: 79%. 1H-NMR (400 MHz,
DMSO) δ: 1.87 (d, 3H, J ) 1.1 Hz); 1.98 (m, 1H); 2.04-2.25 (m,
2H); 2.08 (s, 3H); 2.24 (m, 1H); 3.04 (m, 1H); 3.28 (m, 1H); 3.42
(m, 2H); 3.61 (m, 1H); 3.73 (m, 2H); 3.97 (m, 1H); 4.13 (m, 1H);
4.33 (s, 1H); 5.15 (s, 1H); 5.36 (dd, 1H, J ) 2.6, 6.8 Hz); 5.66 (d,
1H, J ) 8.1 Hz); 5.75 (d, 1H, J ) 2.7 Hz); 6.15 (t, 1H, J ) 7 Hz);
7.42 (d, 1H, J ) 1 Hz); 7.84 (d, 1H, J ) 8 Hz); 11.31 (s, 2H).
13C-NMR (100 MHz, DMSO) δ: 11.9, 20.4, 24.8, 34.5, 38.0, 47.9,
49.9, 60.3, 72.7, 75.6, 83.2, 83.4, 83.7, 89.7, 101.9, 109.9, 136.1,
141.4, 150.0, 150.4, 163.0, 163.6, 169.1. FABMS m/z: 609 (M
+ Na+, 7); 587 (3.5); 391 (3); 369 (3); 329 (3); 307 (11); 289 (7);
176 (21); 154 (64). UV (CH2Cl2/MeOH 1:1) λmax 262 (ꢀ 16 000).
Com p ou n d 13. Dimer 12 (75.8 mg, 129 µmol) was coevapo-
rated with dry pyridine, dried under high vacuum at rt, and
dissolved in dry pyridine (2 mL). TEA (45 mL, 320 µmol), DMAP
(ca. 5 mg), and molecular sieves (6 beads, 4 A) were added, and
the solution was stirred for 15 min at rt before dimethoxytri-
phenyl chloride (DMT-Cl) (90 mg, 258 µmol) was added. The
yellow solution was stirred for 2.5 h at rt. Then, MeOH (2 mL)
was added, and the solution was stirred for an additional 30
min before the mixture was concentrated in vacuo. The residue
was chromatographed on silica (24 g) with CH2Cl2/iPrOH/MeOH/
TEA (94:3:3:0.5 and 92:4:4:0.5) to yield 5′-DMT dimer 13 as a
colorless solid (112.5 mg, 126 µmol). Yield: 97%. 1H-NMR (400
MHz, CDCl3) δ: 1.79 (d, 3H, J ) 0.9 Hz); 1.88-2.05 (m, 1H);
2.04 (s, 3H); 2.15-2.26 (m, 3H); 2.91 (m, 1H); 3.08-3.36 (m, 5H);
3.49 (m, 1H); 3.80 (m, 1H); 3.97 (m, 1H); 3.67 (2Ys, 6H); 4.13
(m, 1H); 5.42 (d, 1H, J ) 8.2 Hz); 5.52 (d, 1H, J ) 1.5 Hz); 5.62
(d, 1H, J ) 6.7 Hz); 6.02 (t, 1H, J ) 6.7 Hz); 6.74 (d, 4H); 6.99
(s, 1H); 7.11 (m, 1H); 7.20 (m, 6H); 7.31 (d, 2H); 7.49 (d, 1H, J
) 8.2 Hz); 9.63 (s, 1H); 9.80 (s, 1H). 13C-NMR (100 MHz, CDCl3)
δSPCLN 12.4, 20.7, 25.1, 36.4, 39.0, 48.9, 49.5, 55.3, 62.5, 73.9,
76.4, 82.3, 83.9, 85.9, 92.6, 102.8, 111.5, 113.4, 127.2, 128.05,
128.12, 130.12, 130.15, 135.21, 135.24, 136.3, 141.7, 144.2, 150.5,
150.6, 158.7, 163.5, 164.0, 169.8. FABMS m/z: 990 (M + H+,
4.7); 888 (1.4); 492 (11); 391 (33); 303 (100). UV (CH2Cl2): λmax
259 (ꢀ 16 900); 238 (ꢀ 18 450).
Com p ou n d 14. Dimer 13 (251 mg, 28 µmol) and diisopro-
pylammonium tetrazolide (DIPAT) (3 mg) were dried under high
vacuum at 40 °C and then dissolved in dry CH3CN (150 µL).
Bis(diisopropylamino)-(â-cyanoethoxy)phosphine (15 µL, 47 µmol)
was added at rt, and the solution was stirred for 3 h. Aqueous
saturated NaHCO3 (5 mL) and CH2Cl2 (5 mL) were added, and
the phases were separated. The organic phase was washed with
brine. The aqueous phase was reextracted twice with CH2Cl2.
The combined organic phases were dried over MgSO4, filtrated,
and concentrated in vacuo to a volume of 1 mL. The product
was precipitated twice with hexane (5 mL) from the concentrated
solution to yield phosphoramidite 14 (two diastereomers) as a
colorless solid (18.5 mg, 17 µmol). Yield: 60%. 1H-NMR
(selected signals of diastereomeric mixture, 300 MHz, CDCl3)
δ: 1.12-1.34 (m, 2H); 1.91 (m, 3H, J ) 0.9 Hz); 2.14 (2Ys, 3H);
2.38, 2.63 (dt, 4H); 3.58 (dt, 4H); 3.69 (2Ys, 6H); 5.45 (d, 1H);